United States · FDA National Drug Code directory
Pregabalin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-314_9d6ac8b5-77e4-4c4f-9c24-8d3043149146
- Product NDC
- 71610-314
- Form
- CAPSULE
- Composition / generic term
- PREGABALIN
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190719
- Source listing expiry
- 20261231
Source-listed ingredients
- PREGABALIN — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (71610-314-30) · 71610-314-30
- 56 CAPSULE in 1 BOTTLE (71610-314-46) · 71610-314-46
- 60 CAPSULE in 1 BOTTLE (71610-314-53) · 71610-314-53
- 210 CAPSULE in 1 BOTTLE (71610-314-66) · 71610-314-66
- 120 CAPSULE in 1 BOTTLE (71610-314-70) · 71610-314-70
- 150 CAPSULE in 1 BOTTLE (71610-314-75) · 71610-314-75
- 180 CAPSULE in 1 BOTTLE (71610-314-80) · 71610-314-80
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →